Five Sources That Stay on the Problem: Appraising the Evidence for Preventing Opioid Constipation After Joint Replacement
Student Name
American College of Education
NUR4093: Senior Capstone Experience for Nursing
Module 2 Assignment
Instructor Name
March 8, 2027
The Problem and the Question
The capstone problem, defined in the previous module, is a day-three gap: close to half of the unit's elective hip and knee replacement patients, 37 of the 80 reviewed, reached midnight of their third day after surgery with no bowel movement charted, even though most had senna ordered as needed and few ever received it. The unit and baseline are the same composite used throughout this capstone. The question the evidence must answer follows from that problem: for adults receiving opioids after joint replacement, does a scheduled stimulant-based bowel regimen with nurse-led monitoring, compared with docusate plus as-needed laxatives, reduce the proportion without a bowel movement by day three?
Keeping the evidence on that question was harder than finding evidence. A search of CINAHL and PubMed on opioids and constipation after orthopedic surgery returned hundreds of records, many of them studies of new medications for chronic opioid-induced constipation in patients with cancer or chronic pain, and studies of reducing opioid use after joint replacement. Both are relevant to the wider subject. Neither addresses what a nurse can change on this unit next month, so both were set aside. Evidence that is excellent on a neighboring question is still off the problem, and a capstone that drifts to follow it loses the ability to measure its own result.
Clinical Guideline
The 2019 American Gastroenterological Association guideline for treating constipation caused by opioids (Crockett et al., 2019) was developed using a formal evidence review and graded recommendations. Its first recommendation is that traditional laxatives be used as first-line agents for opioid-induced constipation, and it places newer drugs that block opioid receptors in the gut second, for patients whose symptoms persist despite laxatives. The guideline addresses treatment rather than prevention and draws mostly on studies of patients with chronic pain, so its fit to short-term postoperative patients is indirect. Its strength lies in its method and its clear message that ordinary laxatives come first, which supports using a stimulant laxative rather than moving straight to newer or more expensive options.
For nursing practice on this unit, the guideline's practical meaning is that the answer to the baseline problem is not a new drug but better use of old ones. Stimulant laxatives such as senna and osmotic agents such as polyethylene glycol are inexpensive, familiar to prescribers and already on the hospital formulary. The guideline also implies an escalation sequence, conventional laxatives first and other agents only when they fail, that a nursing protocol can reflect by specifying when a nurse should give an as-needed osmotic agent and when to call the surgical team. The appraisal therefore treats the guideline as moderate-strength support for the direction of the change, even though it was not written for postoperative prevention.
Two Randomized Trials
Tarumi et al. (2013) conducted a randomized, double-blind, placebo-controlled trial in 74 hospice patients, comparing docusate plus sennosides with placebo plus sennosides. There were no significant differences in stool frequency, volume, consistency, difficulty or completeness of evacuation. The design is strong, with randomization, blinding and a placebo control, though the sample was small and hospice patients differ from joint replacement patients in age, illness and opioid duration. For this capstone the trial's contribution is specific and important: it suggests that the docusate most patients on the unit receive adds nothing to a stimulant laxative, so it cannot be relied on as the main prevention strategy.
Marciniak et al. (2014) randomized adults with opioid-induced constipation after orthopedic surgery to lubiprostone or senna in a double-blind, active-comparator trial. Among 56 participants included in the intention-to-treat analysis, bowel symptoms and constipation-related quality of life improved in both groups, with no significant difference between them, and senna performed better on two individual symptoms, completeness of bowel movement and abdominal pain. The trial is the closest in population to this capstone, orthopedic surgery patients with a mean age of about 71, though it studied treatment of established constipation rather than prevention, and its sample was small. It supports senna as an effective, inexpensive option in this population.
Implementation Evidence and Background
McPeake et al. (2011) introduced their bowel protocol to an adult ICU in three phases: a baseline audit of 26 patients and a staff focus group, a protocol with a new bowel care chart and education, and an audit of 27 patients afterward. Documentation of bowel care improved significantly, and constipation incidence fell by 20.7 percent, though that reduction was not statistically significant in the small sample. The study is a before-and-after design with no control group and a different patient population, so its outcome findings are weak evidence. Its value for this capstone is practical: it shows that a protocol combined with a chart and staff education can change nursing documentation and attention to bowel care, which is precisely the gap the baseline revealed.
Kumar et al. (2014) reviewed the pathophysiology, clinical consequences and management of opioid-induced constipation. As a narrative review it ranks low as evidence for an intervention, but it explains why prevention matters: opioids slow motility and increase fluid absorption in the gut, tolerance to these effects develops poorly and the resulting constipation can reduce quality of life and adherence to pain treatment. It supplies the rationale for acting early rather than waiting for symptoms.
Synthesis
Taken together, the five sources point in one direction despite their individual limits. The guideline establishes that conventional laxatives are the first-line approach. The docusate trial suggests that the stool softener most often ordered on this unit adds little, and the orthopedic trial suggests that senna is effective in a similar population. The implementation study suggests that a protocol with a documentation chart and education can change how consistently nurses attend to bowel care. The review explains why earlier action is better than later. No single source tests the exact intervention the capstone will propose in the exact population, which is common for nursing practice problems. The evidence does not prove that a scheduled senna-based protocol will cut the day-three rate on this unit, but it makes that protocol the most defensible change to try and measure.
The main gap is prevention evidence in postoperative joint replacement patients specifically. That gap is a reason to measure carefully, with the same day-three definition used at baseline, rather than a reason to wait for a trial that may never be done.
Conclusion
The evidence gathered for this capstone stays on the narrowed problem and supports a specific change: replacing docusate as the default bowel regimen after joint replacement with a scheduled stimulant laxative, beginning on the day of surgery, supported by a nurse-led monitoring protocol and a clear escalation step if no bowel movement occurs by the second postoperative day. The next module will turn that change into a plan with a setting, the people responsible, a sequence and the resistance expected.
References
Crockett, S. D., Greer, K. B., Heidelbaugh, J. J., Falck-Ytter, Y., Hanson, B. J., & Sultan, S. (2019). American Gastroenterological Association Institute guideline on the medical management of opioid-induced constipation. Gastroenterology, 156(1), 218-226. https://doi.org/10.1053/j.gastro.2018.07.016
Kumar, L., Barker, C., & Emmanuel, A. (2014). Opioid-induced constipation: Pathophysiology, clinical consequences, and management. Gastroenterology Research and Practice, 2014, Article 141737. https://doi.org/10.1155/2014/141737
Marciniak, C. M., Toledo, S., Lee, J., Jesselson, M., Bateman, J., Grover, B., & Tierny, J. (2014). Lubiprostone vs senna in postoperative orthopedic surgery patients with opioid-induced constipation: A double-blind, active-comparator trial. World Journal of Gastroenterology, 20(43), 16323-16333. https://doi.org/10.3748/wjg.v20.i43.16323
McPeake, J., Gilmour, H., & MacIntosh, G. (2011). The implementation of a bowel management protocol in an adult intensive care unit. Nursing in Critical Care, 16(5), 235-242. https://doi.org/10.1111/j.1478-5153.2011.00451.x
Tarumi, Y., Wilson, M. P., Szafran, O., & Spooner, G. R. (2013). Randomized, double-blind, placebo-controlled trial of oral docusate in the management of constipation in hospice patients. Journal of Pain and Symptom Management, 45(1), 2-13. https://doi.org/10.1016/j.jpainsymman.2012.02.008
How this NUR 4093 Module 2 example is structured
NUR 4093 Module 2 typically gathers and appraises the evidence that stays on the narrowed problem, not the wider subject; your classroom's instructions decide the appraisal tool and the number of sources. This example begins by restating the problem and the question it generates, then explains how sources were chosen and which attractive sources were left out because they drifted from the problem. Each source is appraised in the same order, design, findings, strength and fit, and a synthesis section weighs them together. The conclusion names the practice change the evidence supports, which becomes the plan in the next module.
NUR4093 Module 2 questions, answered
What does NUR4093 Module 2 usually ask for?
NUR4093 Module 2 typically asks students to gather and appraise the evidence for the capstone problem defined in Module 1. Many sections expect a set number of sources, an appraisal of each for design and quality, and a synthesis that states what the evidence supports. Your classroom's instructions decide the number of sources and whether an evidence table is required.
How do I keep a capstone evidence review focused?
Turn the problem statement into a specific question and judge every source against it. Sources that are excellent but address a neighboring question, such as a different population or an intervention outside nursing scope, should be named and set aside. A short explanation of what you excluded and why often earns credit.
What if no study tests my exact intervention in my exact population?
That is common in nursing capstones. Appraise the closest evidence, say clearly how each source fits or differs, and build the case from several sources that point the same way. Then treat the implementation as something to measure carefully, using the same definition as your baseline.
Write yours, or have the desk draft it
This paper is an original model document written by our desk, not a submitted student paper and not an official American College of Education document. Read it for the moves, then write your own to the instructions in your classroom. If you want one built to your exact prompt and rubric, the first custom sample is free and arrives in 24 to 48 hours.